Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950134-99-002424
Filing Date
1999-03-31
Accepted
1999-03-31 00:00:00
Documents
5
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR END DECEMBER 31, 1998 10-K405 207131
2 1996 STOCK OPTION PLAN EX-10.35 36980
3 STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE EX-11 1370
4 CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS EX-23 646
5 FINANCIAL DATA SCHEDULE EX-27 2057
  Complete submission text file 0000950134-99-002424.txt   250094
Mailing Address 9000 HARRY HINES BLVD DALLAS TX 75235
Business Address 9000 HARRY HINES BLVD STE 330 DALLAS TX 75235 2143532922
CYTOCLONAL PHARMACEUTICS INC /DE (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-26078 | Film No.: 99582981
SIC: 2834 Pharmaceutical Preparations